Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | WHR1 | P49842 | 1/20 | 0.38 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24275077 | 0.95 | MEN1 (0.46) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL24275170 | 0.94 | MEN1 (0.40) | MEN1KMT2AATMWHR1ADORA2A | |
| SCHEMBL24275108 | 0.93 | MEN1 (0.39) | MEN1KMT2AATMWHR1ADORA2A | |
| SCHEMBL24275071 | 0.89 | MEN1 (0.40) | MEN1KMT2AATMWHR1ADORA2A | |
| SCHEMBL24275416 | 0.89 | MEN1 (0.39) | MEN1KMT2AATMWHR1ADORA2A | |
| SCHEMBL24275466 | 0.89 | MEN1 (0.46) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL24275364 | 0.88 | L3MBTL1 (0.41) | MEN1KMT2AATMADORA2AMAPT | |
| SCHEMBL24275547 | 0.88 | MEN1 (0.48) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL26217066 | 0.88 | MEN1 (0.50) | MEN1KMT2AATMWHR1NUDT1 | |
| SCHEMBL24275414 | 0.88 | AHR (0.39) | MEN1KMT2AATMMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220109110-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2022-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220109110-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, LEF1, TMEM109 | MEN1 1505/4885KMT2A 2742/4885ATM 3057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.